Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-29

Clinical Trial Update: Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial [Phase 2]

View source ↗

Summary

Feasibility Phase 2 trial evaluating LET-optimized IMPT as part of definitive chemoradiation for newly diagnosed anal canal squamous cell carcinoma; trial compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LET-optimized Intensity Modulated Proton Therapy (IMPT)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Anal Canal Squamous Cell Carcinoma, Stage I Anal Cancer AJCC v8 | Phase 2 | Status: COMPLETED | Results posted: 2023-06-29